COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Intrasense et Guerbet annoncent la certification PMDA au Japon de DUOnco™ Pancreas, un logiciel d’IA conçu pour accompagner l’analyse des régions pancréatiques sur scanner injecté
Intrasense et Guerbet annoncent la certification PMDA au Japon de DUOnco™ Pancreas, un logiciel d’IA pour l'analyse pancréatique sur scanner injecté. Un outil d'assistance pour les radiologues -
COMMUNIQUÉ DE PRESSE
Global Enterprises Face AI Scaling Crisis: 77% View AI as Board-Level Priority, Yet Two-Thirds Rely on Legacy Infrastructure
Global Enterprises Face AI Scaling Crisis: New report from Tata Communications and Bloomberg Media Studios reveals enterprises struggling to scale AI due to outdated infrastructure, despite recognizing AI as a board-level priority -
-
-
-
COMMUNIQUÉ DE PRESSE
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.54 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion
Bitmine Immersion Technologies announces 5.54 million ETH tokens and $9.6 billion total holdings including cash and 'moonshots'. Company aims to acquire 5% of ETH -
COMMUNIQUÉ DE PRESSE
As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment - with Superior Oral Administration and Escape Resistance Features Over Antibodies
NanoViricides, Inc. proposes Phase II Trial of NV-387 Oral Gummies for Bundibugyo Ebolavirus. Potential treatment for current outbreak, offering oral delivery of broad-spectrum antiviral drug
![Logo de [UNKNOWN]](https://logos.symex.be/img/.jpg)
